Givaudan's organic sales growth in the third quarter beat market expectations by nearly twofold, as demand for luxury perfumes drove a sharp acceleration in its fragrance business.
The Swiss fragrance, flavour and cosmetic ingredients manufacturer reported like-for-like sales growth of 8.6% in the quarter, against analyst expectations of 4.7%. The result lifted its shares by nearly 7% to a 15-month high.
Fragrance & Beauty leads growth
In the first nine months, the Fragrance & Beauty division generated CHF 3.15 billion (US$3.78 billion), up 8.8% like-for-like and ahead of the 8% growth recorded in the same period a year earlier. The division accounted for roughly 53% of group sales over that period.
In the third quarter alone, Fragrance & Beauty posted sales of CHF 1.14 billion (US$1.37 billion), with like-for-like growth of 13.5%, up from 6.8% in the third quarter of 2025. At group level, Givaudan recorded sales of CHF 5.89 billion (US$7.08 billion) in the first three quarters.
Fine fragrance drives the quarter
Fine Fragrance sales rose 15.3% like-for-like, building on a competitive prior-year comparable of 18.7% and marking sustained double-digit growth. Reuters reported that analysts at Vontobel and Jefferies estimated Fine Fragrance sales grew around 31% organically in the third quarter alone.
Consumer Products sales increased 9.3% like-for-like, compared with 5.9% in the prior-year period, indicating that fragrance demand extends beyond fine perfumery into personal, oral, home and fabric care. By contrast, Fragrance Ingredients and Active Beauty combined fell 2.5%, against like-for-like growth of 1.5% in the first nine months of 2025.
Vontobel analyst Arben Hasanaj said the acceleration should reinforce confidence in Givaudan's growth profile and resilience, according to Reuters.
Regional picture
Asia Pacific was the fastest-growing geography at group level, with sales up 10.6% like-for-like in the first nine months of 2026, compared with 4.6% a year earlier. Within Taste & Wellbeing, the region grew 7.1% like-for-like, against a 0.5% decline in the same period of 2025.
Sales in South Asia, Africa and the Middle East rose 4.1% like-for-like, below the 8.8% recorded a year earlier. Europe grew 1.5% and Latin America 1.1%, both slower than their prior-year comparables of 3.8% and 3.1% respectively. High-growth markets advanced 7.9%, against 2.7% in mature markets.
North America was the most challenging region. Taste & Wellbeing sales there fell 3.3% like-for-like, compared with a 3.9% decline in the first nine months of 2025, although the region overall grew 1.1%. Givaudan attributed the drop primarily to continued weakness in its Health and Functional business unit and to US tariff refunds made to its customers during the third quarter of 2026.
Acquisitions and currency
Givaudan's like-for-like figures exclude acquisitions. On a reported basis, acquisitions contributed 2.8% to Fragrance & Beauty growth over the nine-month period, while currency translation had a negative impact of 3.8%. At group level, acquisitions contributed 1.4%. The company highlighted two transactions: the acquisitions of Belle Aire Creations for CHF 62 million (US$74.48 million) and Vollmens Fragrances for CHF 20 million (US$24 million).
The results had a positive ripple effect across the sector. Reuters reported that peers including dsm-firmenich, Novonesis and Symrise saw their shares rise between 1.6% and 3.1% in early trading following the update.
Givaudan said the figures point to continued appetite for fragrances among consumers and brands, with potential for growth in fine fragrances, fragrance ingredient differentiation and premiumisation. The company said its consistency amid geopolitical and macroeconomic volatility demonstrates market resilience.
